The onset of menopause is accompanied by a significant drop in blood estradiol levels, the main symptom of which is hot flashes. These are present in 80% of menopausal women and are debilitating in 25% of cases. Although estrogen therapy is the most effective treatment for managing menopausal symptoms, numerous non-hormonal alternatives, both pharmacological and non-pharmacological, have been evaluated for managing menopausal symptoms. Among these, hypnosis has shown promise in several studies. However, to our knowledge, there are no studies that evaluate the longer-term effectiveness of hypnotherapy on menopausal symptoms (beyond 3 months after the start of treatment). Furthermore, there is very little data on the effectiveness of hypnotherapy on the overall quality of life of these women, independent of hot flashes, nor on other symptoms related to menopause. A first pilot study, neither randomized nor controlled, is currently underway, and we hope to continue the project with a robust controlled study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
94
For the experimental group: two hypnosis sessions with the nurse
For the experimental group: reinforcement of the hypnosis technique with a group self-hypnosis session
For the control group: unstructured supportive interview with the nurse
Completion of quality of life questionnaires at inclusion, at 3 months and at 6 months
Centre de ménopause, Hôpital Paule de Viguier, 330 avenue Grande Bretagne
Toulouse, Oui, France
Evaluation of the effectiveness at 6 months of hypnotherapy on the overall quality of life of menopausal women compared to a simple empathic support technique.
The effectiveness of hypnotherapy in treating the side effects of menopause will be assessed with the score calculated from the MENQOL questionnaire at 6 months
Time frame: 6 months after the inclusion
Evaluating the effectiveness of hypnotherapy on women's overall quality of life at 3 months
The effectiveness of hypnotherapy in treating the side effects of menopause will be assessed with the score calculated from the MENQOL questionnaire at 3 months
Time frame: 3 months after the inclusion
Evaluate the effectiveness of hypnotherapy on the frequency of hot flashes
Measurement of the total number of hot flashes recorded daily over 7 days
Time frame: 6 months after the inclusion
Evaluation of the tolerance of hypnotherapy
Measuring tolerance using an adverse event questionnaire
Time frame: 6 months after the inclusion
Evaluation of the effectiveness of hypnotherapy on depressive symptoms
Depressive symptoms will be assessed using the validated Patient Health Questionnaire-9 (PHQ-9).
Time frame: 6 months after the inclusion
Evaluation of the effectiveness of hypnotherapy on sleep disorders
Sleep disorders will be assessed using the Insomnia Severity Index (ISI) questionnaire.
Time frame: 6 months after the inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.